(Q38401463)

English

ENMD-2076, an oral inhibitor of angiogenic and proliferation kinases, has activity in recurrent, platinum resistant ovarian cancer

scientific article published on 21 August 2012

Statements

ENMD-2076, an oral inhibitor of angiogenic and proliferation kinases, has activity in recurrent, platinum resistant ovarian cancer (English)
Afra Yehwalashet
Graham Fletcher
Richard D Brokx
Vincent Castonguay
Carolyn F Sidor

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit